Madison, WINCT05971446Now EnrollingIRB Ready

Hypoxic-Ischemic Encephalopathy Clinical Trial in Madison, WI

Access cutting-edge hypoxic-ischemic encephalopathy treatment through this clinical trial at a research site in Madison. Study-provided care at no cost to qualified participants.

Sponsored by University of Wisconsin, Madison

Quick Self-Assessment

See if you qualify for this Madison location

Preparing your pre-screening questions…

Expert Care in Madison

Access hypoxic-ischemic encephalopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hypoxic-ischemic encephalopathy treatment provided free

Apply for This Madison Location

Check if you qualify for this hypoxic-ischemic encephalopathy clinical trial in Madison, WI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Madison

    Convenient for WI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Madison site if eligible
  4. 4Begin participation

About This Hypoxic-Ischemic Encephalopathy Study in Madison

The purpose of this research study is to gather more information on how eye injury is related to a baby's future development and see if eye function and brain test results can be used, along with current measures, to better diagnose and treat babies with hypoxic-ischemic encephalopathy (HIE). Participants will undergo up to two eye exam sessions, involving both Visual Evoked Potential (VEP) and Electroretinogram (ERG) exams.

Sponsor: University of Wisconsin, Madison

Who Can Participate

Inclusion Criteria

Inpatient Neonates diagnosed with HIE
Pediatric patients who are less than 78 hours of age at the time of enrollment
Participants whose parent/legal guardian is able to complete consenting process in English HIE Neonate

Exclusion Criteria

Participants with prenatally diagnosed or congenital brain and/or eye abnormalities not associated with HIE, including but not limited to microphthalmia, anophthalmia, congenital cataract, eye or eyelid coloboma, congenital glaucoma, CMV retinitis, optic nerve hypoplasia, aniridia, cryptophthalmos, globe abnormalities
Participants who have a known central nervous system illness other than HIE, including but not limited to congenital brain malformations or congenital hydrocephalus
Participants whose parent/legal guardian is unable to provide informed consent, including participants who are in foster care, participants within state custody, and participants of minor parents Waisman, AFCH NBFU, or CERU Clinic HIE Patient Inclusion Criteria:
Pediatric patients who have a diagnosis of HIE and present to the Newborn Follow Up Clinic
Pediatric patients who are less than 36 months of age at the time of enrollment
Participants whose parent/legal guardian is able to complete consenting process in English Waisman, AFCH NBFU, or CERU Clinic HIE Patient Exclusion Criteria:
Participants with prenatally diagnosed or congenital brain and/or eye abnormalities not associated with HIE, including but not limited to microphthalmia, anophthalmia, congenital cataract, eye or eyelid coloboma, congenital glaucoma, CMV retinitis, optic nerve hypoplasia, aniridia, cryptophthalmos, globe abnormalities
Participants who have a known central nervous system illness not associated with HIE and its complications. Complications may include seizures, hydrocephalus, and stroke, which are NOT exclusionary. Examples of exclusionary conditions include but are not limited to traumatic brain injury outside the perinatal period, meningitis, or diagnosis of brain tumor
Participants whose parent/legal guardian is unable to provide informed consent, including participants who are in foster care, participants within state custody, and participants of minor parents Well Baby Inclusion Criteria:
Patient in Meriter's Newborn Nursery
≥37 and \<42 weeks gestational age
5-minute Apgar Score ≥7
Occipital Frontal Circumference (OFC) is within average limits for age (\<97th percentile and \>3rd percentile) Well Baby Exclusion Criteria:
Admitted to the NICU for any reason
Known genetic abnormality
Diagnosed with HIE
Diagnosed with Hypoglycemia
Diagnosed with Hyperbilirubinemia requiring phototherapy
Identified prenatal exposure to substances, including illicit drugs, alcohol, and/or tobacco
Known or suspected neonatal infection requiring treatment (e.g., antibiotics)
TORCH infections
Abnormal newborn hearing screen
Abnormal toxicology screening
Identified as large for gestational age (LGA) or small for gestational age (SGA)
Participants with prenatally diagnosed or congenital eye abnormalities, including but not limited to microphthalmia, anophthalmia, congenital cataract, eye or eyelid coloboma, congenital glaucoma, CMV retinitis, optic nerve hypoplasia, aniridia, cryptophthalmos, globe abnormalities, and nystagmus
Subjects who have a known central nervous system illness or malformation, including but not limited to congenital brain malformations or congenital hydrocephalus
Participants whose parent/legal guardian is unable to provide informed consent, including subjects who are in foster care, subjects within state custody, and subjects of minor parents
The attending medical team does not approve

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Madison?

Yes, this clinical trial (NCT05971446) has an active research site in Madison, WI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hypoxic-Ischemic Encephalopathy Treatment Options in Madison, WI

If you're searching for hypoxic-ischemic encephalopathy treatment options in Madison, WI, this clinical trial (NCT05971446) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Madison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypoxic-ischemic encephalopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hypoxic-ischemic encephalopathy clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Madison, WI

See all heart attack clinical trials recruiting in Madison — not just this study.

Browse Heart Attack Trials in Madison →

Browse More Trials by Condition

Heart Attack TrialsPulmonary Hypertension TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Madison?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Madison, WI